Clinical Trial Update: A Study to Determine if Levetiracetam Will Assist Those Suffering From Chronic Idiopathic Axonal Polyneuropathy. [Phase 2]

View source ↗

Summary

This document reports a Phase 2 clinical trial evaluating levetiracetam in chronic idiopathic axonal polyneuropathy, which has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Axonal Polyneuropathy

Drugs mentioned

• LEVETIRACETAM (levetiracetam)

Snippet

Sponsor: Vanderbilt University | Conditions: Chronic Idiopathic Axonal Polyneuropathy | Phase 2 | Status: COMPLETED